{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:50:20Z","timestamp":1792709420132,"version":"4.5.0"},"reference-count":324,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Liposome Research"],"published-print":{"date-parts":[[2023,1,2]]},"DOI":"10.1080\/08982104.2022.2069809","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T06:05:07Z","timestamp":1652249107000},"page":"1-33","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":21,"title":["Rationale utilization of phospholipid excipients: a distinctive tool for progressing state of the art in research of emerging drug carriers"],"prefix":"10.1080","volume":"33","author":[{"given":"Koilpillai","family":"Jebastin","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, SRM College of Pharmacy, SRM Institute of Science and Technology","place":["Kattankulathur, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4246-5351","authenticated-orcid":false,"given":"Damodharan","family":"Narayanasamy","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, SRM College of Pharmacy, SRM Institute of Science and Technology","place":["Kattankulathur, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,5,11]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.langmuir.7b01273"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2021.101129"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.22159\/ijap.2019v11i1.29077"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/1556-276X-8-102"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.2174\/156720111795767906"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.4155\/ppa-2019-0020"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.22270\/ujpr.v2i1.RW1"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/3041969"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2736(80)90118-2"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199856050-00001"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2007.04.007"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00715-19"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00025-19"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01467-21"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10143"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.5530\/jyp.2018.2s.11"},{"issue":"1","key":"e_1_3_3_18_1","first-page":"59","article-title":"Novasome: a pioneering advancementin vesicular drug delivery","volume":"13","author":"Aslam Abdul Rahiman C.A.","year":"2021","unstructured":"Aslam Abdul Rahiman, C.A., et\u00a0al., 2021. Novasome: a pioneering advancementin vesicular drug delivery. International journal of applied pharmaceutics, 13(1), 59\u201364. Available from: https:\/\/innovareacademics.in\/journals\/index.php\/ijap\/article\/view\/39528","journal-title":"International journal of applied pharmaceutics"},{"key":"e_1_3_3_19_1","unstructured":"Authority H Product Regulatory n.d. Available from: http:\/\/www.hpra.ie\/img\/uploaded\/swedocuments\/LicenseSPC_PA1329-009-001_11082014151041.pdf"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-815673-5.00010-6"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02540126"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.3109\/10611869408996811"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm396"},{"key":"e_1_3_3_24_1","unstructured":"Bansal S. et\u00a0al. 2012. A comparative review on vesicular drug delivery system and stability issues."},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-3084(99)00072-9"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201804067"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2016.1201059"},{"issue":"3","key":"e_1_3_3_28_1","first-page":"243","article-title":"[Naked DNA and lipoplexes applications in cancer gene therapy]","volume":"94","author":"Bertin S.","year":"2007","unstructured":"Bertin, S., et\u00a0al., 2007. [Naked DNA and lipoplexes applications in cancer gene therapy]. Bulletin du cancer, 94 (3), 243\u2013252. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17371766","journal-title":"Bulletin du cancer"},{"issue":"5","key":"e_1_3_3_29_1","first-page":"368","article-title":"Ethosomes: a novel delivery system for antifungal drugs in the treatment of topical fungal diseases","volume":"47","author":"Bhalaria M.K.","year":"2009","unstructured":"Bhalaria, M.K., Naik, S., and Misra, A.N., 2009. Ethosomes: a novel delivery system for antifungal drugs in the treatment of topical fungal diseases. Indian journal of experimental biology, 47 (5), 368\u2013375. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19579803","journal-title":"Indian journal of experimental biology"},{"key":"e_1_3_3_30_1","first-page":"516","article-title":"Lyophilization\/freeze drying \u2013 a review","volume":"4","author":"Bhambere D.","year":"2015","unstructured":"Bhambere, D., et\u00a0al., 2015. Lyophilization\/freeze drying \u2013 a review. World journal of pharmaceutical research, 4, 516\u2013543.","journal-title":"World journal of pharmaceutical research"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.5958\/0974-360X.2019.00699.1"},{"issue":"1","key":"e_1_3_3_32_1","first-page":"1","article-title":"Simulating the digestion of lipid-based drug delivery systems (LBDDS): overview of in\u00a0vitro lipolysis models","volume":"61","author":"Bolko K.","year":"2014","unstructured":"Bolko, K., Zvonar, A., and Ga\u0161perlin, M., 2014. Simulating the digestion of lipid-based drug delivery systems (LBDDS): overview of in\u00a0vitro lipolysis models. Acta chimica slovenica, 61 (1), 1\u201310. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24664320","journal-title":"Acta chimica slovenica"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24173139"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1021\/nn7002025"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.21650"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2007.04.013"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.3797\/scipharm.1305-11"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2021.05.005"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics9020012"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v21.i1.10"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2007.04.013"},{"issue":"1","key":"e_1_3_3_42_1","first-page":"132","article-title":"Chemical and physical stability considerations for lipid-based drug formulations","volume":"11","author":"Cannon J.B.","year":"2008","unstructured":"Cannon, J.B., 2008. Chemical and physical stability considerations for lipid-based drug formulations. American pharmaceutical review, 11(1), 132\u2013138.","journal-title":"American pharmaceutical review"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2019.100988"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-2736(01)00369-8"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1080\/03639040500215750"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.2003.01151.x"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cherd.2014.09.008"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2005.06.005"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1208\/pt060350"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.22270\/jddt.v9i1.2198"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2008.11.017"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2007.09.010"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.5897\/AJPPX2013.0004"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.2174\/1567201811666141021142606"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2007.05.037"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.3109\/10731199509117949"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s003960000336"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)38159-1"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20780"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2007.10.013"},{"key":"e_1_3_3_61_1","article-title":"Bioavailability enhancement \u2013 analysis of the historical use of solubilization technologies","author":"Crew M.","year":"2014","unstructured":"Crew, M., 2014. Bioavailability enhancement \u2013 analysis of the historical use of solubilization technologies. Drug development & delivery.\u00a014(2), 22.","journal-title":"Drug development & delivery"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.3390\/nano11010105"},{"key":"e_1_3_3_63_1","unstructured":"CSIR 2019. Cationic liposome-encapsulated camptothecin (CPT) with DOX enhanced anticancer efficacy in synergistic action to improve the therapeutic index. United States; US10426728B2."},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20750"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/0169-409X(89)90024-0"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-3084(86)90067-8"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.78.5.2786"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2008.03.021"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules15107313"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1111\/1541-4337.12606"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.3109\/21691401.2014.953633"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpj.2014.03.037"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2010.07.015"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphotobiol.2004.11.022"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2005.02.009"},{"key":"e_1_3_3_76_1","unstructured":"Dhiman A. et\u00a0al. 2012. Potential phytotherapeutic agents in design of ethosomes: a review."},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1124\/mi.6.2.7"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.3109\/10717544.2014.896058"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-006-9092-4"},{"key":"e_1_3_3_80_1","unstructured":"Drummond D.C. et\u00a0al. 2019. Stabilizing camptothecin pharmaceutical compositions. United States; US10456360B2."},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01875709"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2014.01.002"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-384947-2.00540-7"},{"key":"e_1_3_3_84_1","unstructured":"EMA. n.d.-a. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/comirnaty-epar-product-information_en.pdf"},{"key":"e_1_3_3_85_1","unstructured":"EMA n.d.-b. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/vyxeos-liposomal-epar-product-information_en.pdf."},{"key":"e_1_3_3_86_1","unstructured":"EMA n.d.-c. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/2535\/smpc"},{"key":"e_1_3_3_87_1","unstructured":"EMA n.d.-d. Summary of product characteristics. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/onivyde-pegylated-liposomal-epar-product-information_en.pdf"},{"key":"e_1_3_3_88_1","unstructured":"EMA n.d.-e. Summary for the public. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/overview\/mepact-epar-summary-public_en.pdf"},{"key":"e_1_3_3_89_1","unstructured":"EMA n.d.-f. Summary of product characteristics. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/mepact-epar-product-information_en.pdf"},{"key":"e_1_3_3_90_1","unstructured":"EMA n.d.-g. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/aptivus-epar-product-information_en.pdf"},{"key":"e_1_3_3_91_1","unstructured":"EMA n.d.-h. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/referral\/isotretinoin-article-29-referral-annex-i-ii-iii_en.pdf"},{"key":"e_1_3_3_92_1","unstructured":"EMA n.d.-i. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/kaletra-epar-product-information_en.pdf"},{"key":"e_1_3_3_93_1","unstructured":"EMA n.d.-j. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/targretin-epar-product-information_en.pdf"},{"key":"e_1_3_3_94_1","unstructured":"EMA n.d.-k. Summary of product characteristics. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/myocet-liposomal-previously-myocet-epar-product-information_en.pdf"},{"key":"e_1_3_3_95_1","unstructured":"EMA n.d.-l. Scientific discussion. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-discussion\/myocet-epar-scientific-discussion_en.pdf."},{"key":"e_1_3_3_96_1","doi-asserted-by":"publisher","DOI":"10.1201\/9781420046649.ch2"},{"key":"e_1_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2018.09.047"},{"key":"e_1_3_3_98_1","first-page":"208","article-title":"Sphingosome vescicular system","volume":"41","author":"Fathima K.M.","year":"2016","unstructured":"Fathima, K.M., et\u00a0al., 2016. Sphingosome vescicular system. International journal of pharmaceutics sciences review and research, 41, 208\u2013213.","journal-title":"International journal of pharmaceutics sciences review and research"},{"key":"e_1_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.2147\/tcrm.s12160436"},{"key":"e_1_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12010029"},{"key":"e_1_3_3_101_1","unstructured":"FDA and CDER 2014. Guidance for industry CMC postapproval manufacturing changes to be documented in annual reports."},{"key":"e_1_3_3_102_1","unstructured":"FDA and CDER 2018. Liposome drug products chemistry manufacturing and controls; human pharmacokinetics and bioavailability; and labeling documentation."},{"key":"e_1_3_3_103_1","unstructured":"FDA and CDER 2021. Liposome drug products: chemistry manufacturing and controls; human pharmacokinetics and bioavailability; and labeling documentation. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/liposome-drug-products-chemistry-manufacturing-and-controls-human-pharmacokinetics-and"},{"key":"e_1_3_3_104_1","unstructured":"FDA Application n.d. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/anda\/2000\/065003_gengraf_toc.cfm#:\u223c:text=ApprovalDate%3A05%2F12%2F2000"},{"key":"e_1_3_3_105_1","unstructured":"FDA 2021. CFR-Code of Federal Regulations Title 21. Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/cfrsearch.cfm?fr=201.57"},{"key":"e_1_3_3_106_1","unstructured":"FDA 2022. Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cder\/iig\/index.cfm."},{"key":"e_1_3_3_107_1","unstructured":"FDA CDER and CBER 1999. Guidance for industry population pharmacokinetics."},{"key":"e_1_3_3_108_1","unstructured":"FDA et\u00a0al. 2011. Guidance for industry process validation: general principles and practices. Available from: https:\/\/www.fda.gov\/files\/drugs\/published\/Process-Validation\u2013General-Principles-and-Practices.pdf"},{"key":"e_1_3_3_109_1","unstructured":"FDA n.d.-a. Available from: https:\/\/www.fda.gov\/news-events\/fda-brief\/fda-brief-fda-approves-new-use-exparel-nerve-block-pain-relief-following-shoulder-surgeries#:\u223c:text=The%20U.S.%20Food%20and%20Drug following%20shoulder%20surgery%20in%20adults"},{"key":"e_1_3_3_110_1","unstructured":"FDA n.d.-b. https:\/\/www.medicines.org.uk\/emc\/product\/11802\/smpc."},{"key":"e_1_3_3_111_1","unstructured":"FDA n.d.-c. Highlights of prescribing information. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/202497s011lbl.pdf."},{"key":"e_1_3_3_112_1","unstructured":"FDA n.d.-d. Prescribing information. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2005\/021039s017lbl.pdf"},{"key":"e_1_3_3_113_1","unstructured":"FDA n.d.-e. Summary of product characteristics. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/norvir-epar-product-information_en.pdf"},{"key":"e_1_3_3_114_1","unstructured":"FDA n.d.-f. Highlights of prescribing information. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2007\/050718s029lbl.pdf"},{"key":"e_1_3_3_115_1","unstructured":"FDA n.d.-g. Available from: https:\/\/www.fda.moph.go.th\/sites\/drug\/Summary\/1C_91_50_NC_Epaxal.pdf"},{"key":"e_1_3_3_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118817"},{"key":"e_1_3_3_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(96)00453-X"},{"key":"e_1_3_3_118_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S146315"},{"key":"e_1_3_3_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2221-1691(12)60381-5"},{"key":"e_1_3_3_120_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221810085"},{"key":"e_1_3_3_121_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.30.350"},{"key":"e_1_3_3_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-2736(02)00702-2"},{"key":"e_1_3_3_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2007.04.006"},{"key":"e_1_3_3_124_1","unstructured":"Gilead Sciences Inc. n.d. Available from: https:\/\/www.gilead.com\/\u223c\/media\/Files\/pdfs\/medicines\/other\/ambisome\/ambisome_pi.pdf"},{"key":"e_1_3_3_125_1","doi-asserted-by":"publisher","DOI":"10.4103\/0973-8398.102930"},{"key":"e_1_3_3_126_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.9b00825"},{"key":"e_1_3_3_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(98)00014-3"},{"key":"e_1_3_3_128_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01261"},{"key":"e_1_3_3_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2006.02.005"},{"key":"e_1_3_3_130_1","volume-title":"Biomedical applications of nanoparticles","author":"Grumezescu A.M.","year":"2019","unstructured":"Grumezescu, A.M., 2019. Biomedical applications of nanoparticles. University Politehnica of Bucharest, Bucharest, Romania: Elsevier. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/C20170044579"},{"key":"e_1_3_3_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2011.08.029"},{"key":"e_1_3_3_132_1","unstructured":"Haas M. et\u00a0al. 2019. Liposomal formulations of lipophilic compounds. US; US 10 413 511 B2. Available from: https:\/\/patentimages.storage.googleapis.com\/3f\/a4\/4f\/e87b4a8f5ea062\/US10413511.pdf"},{"key":"e_1_3_3_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0939-6411(98)00037-X"},{"key":"e_1_3_3_134_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2002.tb01230.x"},{"key":"e_1_3_3_135_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2017.107"},{"key":"e_1_3_3_136_1","doi-asserted-by":"crossref","unstructured":"Hattori Y. et\u00a0al. 2005. The role of dioleoylphosphatidylethanolamine (DOPE) in targeted gene delivery with mannosylated cationic liposomes via intravenous route. Journal of controlled release 108 (2\u20133) 484\u2013495. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365905003640","DOI":"10.1016\/j.jconrel.2005.08.012"},{"key":"e_1_3_3_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2007.05.006"},{"key":"e_1_3_3_138_1","doi-asserted-by":"publisher","DOI":"10.1021\/js970300n"},{"key":"e_1_3_3_139_1","unstructured":"Health Canada n.d. Available from: https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/documents\/services\/diseases\/2019-novel-coronavirus-infection\/awareness-resources\/components-covid-19-vaccines\/components-covid-19-vaccines-eng.pdf"},{"key":"e_1_3_3_140_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-3271-9_23"},{"key":"e_1_3_3_141_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2011.02.004"},{"key":"e_1_3_3_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2019.100990"},{"key":"e_1_3_3_143_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2014.05.047"},{"key":"e_1_3_3_144_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0928-0987(03)00174-X"},{"key":"e_1_3_3_145_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2015.02.013"},{"key":"e_1_3_3_146_1","first-page":"1104","article-title":"Recent advances in the use of phospholipid excipients in local or injectable depot formulations","volume":"80","author":"Hoogevest P.","year":"2018","unstructured":"Hoogevest, P. and Luciani, P., 2018. Recent advances in the use of phospholipid excipients in local or injectable depot formulations. Pharmazeutische industrie, 80, 1104\u20131110.","journal-title":"Pharmazeutische industrie"},{"key":"e_1_3_3_147_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejlt.201900411"},{"key":"e_1_3_3_148_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejlt.202000297"},{"key":"e_1_3_3_149_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2013.00143\/abstract"},{"key":"e_1_3_3_150_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2013.00127\/abstract"},{"key":"e_1_3_3_151_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2015.02.018"},{"key":"e_1_3_3_152_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajps.2014.06.001"},{"key":"e_1_3_3_153_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600740738"},{"key":"e_1_3_3_154_1","unstructured":"ICH 2003. Stability testing of new drug substances and products ICH Q1A(R2). ICH Harmonised Tripartite Guideline."},{"issue":"3","key":"e_1_3_3_155_1","first-page":"1011","article-title":"Erythrosomes: large proteoliposomes derived from crosslinked human erythrocyte cytoskeletons and exogenous lipid","volume":"1","author":"Idris N.","year":"2014","unstructured":"Idris, N., et\u00a0al., 2014. Erythrosomes: large proteoliposomes derived from crosslinked human erythrocyte cytoskeletons and exogenous lipid. Austin journal of analytical & pharmaceutical chemistry, 1 (3), 1011.","journal-title":"Austin journal of analytical & pharmaceutical chemistry"},{"key":"e_1_3_3_156_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M501971200"},{"key":"e_1_3_3_157_1","first-page":"408","volume-title":"Advances in controlled and novel drug delivery","author":"Jain N.","year":"2001","unstructured":"Jain, N., 2001. Solid lipid nanoparticles. In: N.K. Jain, ed. Advances in controlled and novel drug delivery. New Delhi: CBS Publishers and Distributors, 408\u2013425."},{"key":"e_1_3_3_158_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2016.10.001"},{"key":"e_1_3_3_159_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2015.09.009"},{"key":"e_1_3_3_160_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2007.09.006"},{"key":"e_1_3_3_161_1","doi-asserted-by":"publisher","DOI":"10.1080\/08982100701527981"},{"key":"e_1_3_3_162_1","doi-asserted-by":"publisher","DOI":"10.5958\/0974-360X.2017.00223.2"},{"key":"e_1_3_3_163_1","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/131.9.2358"},{"key":"e_1_3_3_164_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793%2896%2901021-6"},{"key":"e_1_3_3_165_1","doi-asserted-by":"crossref","unstructured":"Jung C.Y. 1987. [20] Erythrosomes: erythrocyte cytoskeletons coated with exogenous phospholipid as an encapsulating system 217\u2013221. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0076687987490587","DOI":"10.1016\/0076-6879(87)49058-7"},{"issue":"1","key":"e_1_3_3_166_1","first-page":"227","article-title":"Phospholipids as emulsion stabilizers","volume":"184","author":"Kabalnov A.","year":"1996","unstructured":"Kabalnov, A., et\u00a0al., 1996. Phospholipids as emulsion stabilizers. Journal of colloid and interface science, 184 (1), 227\u2013235. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021979796906153","journal-title":"Journal of colloid and interface science"},{"key":"e_1_3_3_167_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2013.10.001"},{"key":"e_1_3_3_168_1","doi-asserted-by":"publisher","DOI":"10.22270\/jddt.v3i5.627"},{"key":"e_1_3_3_169_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:PHAM.0000016282.77887.1f"},{"key":"e_1_3_3_170_1","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.70056"},{"key":"e_1_3_3_171_1","unstructured":"Kelly K. and Jacobs R. 2011. Phospholipid biosynthesis. Available from: http:\/\/lipidlibrary.aocs.org\/Biochemistry\/content.cfm?ItemNumber=39191"},{"key":"e_1_3_3_172_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00575a011"},{"key":"e_1_3_3_173_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1484982"},{"key":"e_1_3_3_174_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj1860591"},{"key":"e_1_3_3_175_1","doi-asserted-by":"publisher","DOI":"10.2174\/0929867043456197"},{"key":"e_1_3_3_176_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(01)00579-8"},{"key":"e_1_3_3_177_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-007-9363-8"},{"key":"e_1_3_3_178_1","unstructured":"Krishna S.V.G. Shivappa N.N. and Vikram S. 2019. A review on liposomes: novel drug delivery system."},{"key":"e_1_3_3_179_1","doi-asserted-by":"publisher","DOI":"10.1159\/000056374"},{"key":"e_1_3_3_180_1","first-page":"87","article-title":"Development and characterization of liposomal drug delivery system for Nimesulide","volume":"2","author":"Kumar A.","year":"2010","unstructured":"Kumar, A., et\u00a0al., 2010. Development and characterization of liposomal drug delivery system for Nimesulide. International journal of pharmacy and pharmaceutical sciences, 2, 87\u201389.","journal-title":"International journal of pharmacy and pharmaceutical sciences"},{"key":"e_1_3_3_181_1","doi-asserted-by":"publisher","DOI":"10.5402\/2012\/474830"},{"key":"e_1_3_3_182_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.01893.x"},{"key":"e_1_3_3_183_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-3084(69)90040-1"},{"key":"e_1_3_3_184_1","doi-asserted-by":"publisher","DOI":"10.1242\/jeb.00334"},{"key":"e_1_3_3_185_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20194706"},{"key":"e_1_3_3_186_1","doi-asserted-by":"publisher","DOI":"10.14412\/2074-2711-2012-2500"},{"key":"e_1_3_3_187_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S108765"},{"key":"e_1_3_3_188_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajps.2014.09.004"},{"key":"e_1_3_3_189_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfa.2021.126447"},{"key":"e_1_3_3_190_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2009.03.052"},{"key":"e_1_3_3_191_1","doi-asserted-by":"crossref","unstructured":"Lin Y.-L. et\u00a0al. 2012. A soybean oil-based liposome-polymer transfection complex as a codelivery system for DNA and subunit vaccines. Journal of nanomaterials 2012 1\u201312. Available from: http:\/\/www.hindawi.com\/journals\/jnm\/2012\/427306\/","DOI":"10.1155\/2012\/427306"},{"key":"e_1_3_3_192_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj3450401"},{"key":"e_1_3_3_193_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-012-9441-7"},{"key":"e_1_3_3_194_1","doi-asserted-by":"publisher","DOI":"10.1515\/acph-2015-0019"},{"key":"e_1_3_3_195_1","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2017.1308915"},{"key":"e_1_3_3_196_1","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.720291\/full"},{"key":"e_1_3_3_197_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2007.08.022"},{"key":"e_1_3_3_198_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2019.183088"},{"key":"e_1_3_3_199_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S2.4.595"},{"key":"e_1_3_3_200_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(99)00043-5"},{"key":"e_1_3_3_201_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2020.101081"},{"key":"e_1_3_3_202_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-3084(82)90053-6"},{"key":"e_1_3_3_203_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009699"},{"key":"e_1_3_3_204_1","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(94)90040-X"},{"key":"e_1_3_3_205_1","doi-asserted-by":"publisher","DOI":"10.2174\/1567201813666160325131831"},{"key":"e_1_3_3_206_1","doi-asserted-by":"publisher","DOI":"10.1021\/cr2002917"},{"key":"e_1_3_3_207_1","doi-asserted-by":"publisher","DOI":"10.3390\/pr9030432"},{"key":"e_1_3_3_208_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics2040339"},{"key":"e_1_3_3_209_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00512-1"},{"key":"e_1_3_3_210_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2018.05.021"},{"key":"e_1_3_3_211_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpj.2008.10.057"},{"key":"e_1_3_3_212_1","unstructured":"Mohan G. 2014. Lipid based drug delivery system: classification drug transport across enterocyte role of lipid chain length in suppression of body fat accumulation."},{"key":"e_1_3_3_213_1","doi-asserted-by":"publisher","DOI":"10.20902\/IJCTR.2018.110826"},{"key":"e_1_3_3_214_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-811942-6.00006-6"},{"key":"e_1_3_3_215_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(02)00217-X"},{"key":"e_1_3_3_216_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2005.09.002"},{"key":"e_1_3_3_217_1","unstructured":"Nagy J.O. et\u00a0al. 2017. Compositions and methods for treating ewing sarcoma. Unitated States; US20170143630A1."},{"key":"e_1_3_3_218_1","doi-asserted-by":"publisher","DOI":"10.1080\/08982104.2018.1517160"},{"key":"e_1_3_3_219_1","doi-asserted-by":"publisher","DOI":"10.7897\/2230-8407.050453"},{"key":"e_1_3_3_220_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11110610"},{"key":"e_1_3_3_221_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(01)00207-1"},{"key":"e_1_3_3_222_1","doi-asserted-by":"publisher","DOI":"10.24966\/NTMB-2044\/100004"},{"key":"e_1_3_3_223_1","doi-asserted-by":"publisher","DOI":"10.5958\/0974-360X.2017.00525.X"},{"key":"e_1_3_3_224_1","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2736(83)90271-7"},{"key":"e_1_3_3_225_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2020.06.002"},{"key":"e_1_3_3_226_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(18)30021-8"},{"key":"e_1_3_3_227_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23040907"},{"key":"e_1_3_3_228_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12090855"},{"key":"e_1_3_3_229_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2013.05.011"},{"key":"e_1_3_3_230_1","doi-asserted-by":"crossref","unstructured":"Pandita A. and Sharma P. 2013. Pharmacosomes: an emerging novel vesicular drug delivery system for poorly soluble synthetic and herbal drugs. ISRN pharmaceutics 2013 1\u201310. Available from: https:\/\/www.hindawi.com\/journals\/isrn\/2013\/348186\/","DOI":"10.1155\/2013\/348186"},{"key":"e_1_3_3_231_1","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2736(74)90175-8"},{"key":"e_1_3_3_232_1","doi-asserted-by":"publisher","DOI":"10.4103\/0975-8453.86290"},{"key":"e_1_3_3_233_1","doi-asserted-by":"publisher","DOI":"10.1080\/0738-859991229170"},{"key":"e_1_3_3_234_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(99)00331-2"},{"key":"e_1_3_3_235_1","doi-asserted-by":"publisher","DOI":"10.1002\/cite.330680721"},{"key":"e_1_3_3_236_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms140611767"},{"key":"e_1_3_3_237_1","unstructured":"Pignatello R. Nicolosi D. and Nicolosi V. 2011. Fusogenic liposomes as new carriers to enlarge the spectrum of action of antibiotic drugs against Gram-negative bacteria."},{"key":"e_1_3_3_238_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2017.01.007"},{"key":"e_1_3_3_239_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(01)00182-X"},{"key":"e_1_3_3_240_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20039"},{"key":"e_1_3_3_241_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2197"},{"key":"e_1_3_3_242_1","doi-asserted-by":"crossref","unstructured":"Pouton C.W. 2000. Lipid formulations for oral administration of drugs: non-emulsifying self-emulsifying and \u2018self-microemulsifying\u2019 drug delivery systems. European journal of pharmaceutical sciences 11 S93\u2013S98. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098700001676","DOI":"10.1016\/S0928-0987(00)00167-6"},{"key":"e_1_3_3_243_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2006.04.016"},{"key":"e_1_3_3_244_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S25310"},{"key":"e_1_3_3_245_1","doi-asserted-by":"publisher","DOI":"10.3109\/02652049109069556"},{"key":"e_1_3_3_246_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2010.05.002"},{"key":"e_1_3_3_247_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S103505"},{"key":"e_1_3_3_248_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01796-15"},{"issue":"1","key":"e_1_3_3_249_1","article-title":"Vesosomes: new prospects in multi compartment vesicular drug delivery system","volume":"12","author":"Raju K.","year":"2020","unstructured":"Raju, K., et\u00a0al., 2020. Vesosomes: new prospects in multi compartment vesicular drug delivery system. International journal of pharmaceutical research, 12 (1), 869-877. Available from: http:\/\/ijpronline.com\/ViewArticleDetail.aspx?ID=12627","journal-title":"International journal of pharmaceutical research"},{"key":"e_1_3_3_250_1","article-title":"Nanocochleate \u2013 a new drug delivery system","volume":"34","author":"Ramasamy T.","year":"2008","unstructured":"Ramasamy, T., et\u00a0al., 2008. Nanocochleate \u2013 a new drug delivery system. FABAD journal of pharmaceutical sciences, 34, 91-101.","journal-title":"FABAD journal of pharmaceutical sciences"},{"key":"e_1_3_3_251_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793%2802%2903406-3"},{"key":"e_1_3_3_252_1","doi-asserted-by":"publisher","DOI":"10.5958\/0974-360X.2018.00892.2"},{"key":"e_1_3_3_253_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2007.10.015"},{"key":"e_1_3_3_254_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2014.05.013"},{"key":"e_1_3_3_255_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2007.08.032"},{"key":"e_1_3_3_256_1","doi-asserted-by":"publisher","DOI":"10.1021\/j100794a011"},{"key":"e_1_3_3_257_1","doi-asserted-by":"publisher","DOI":"10.1021\/jp7095828"},{"key":"e_1_3_3_258_1","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201000752"},{"key":"e_1_3_3_259_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2009.12.018"},{"key":"e_1_3_3_260_1","doi-asserted-by":"publisher","DOI":"10.1021\/jp804641e"},{"key":"e_1_3_3_261_1","doi-asserted-by":"publisher","DOI":"10.5958\/0974-360X.2019.01038.2"},{"key":"e_1_3_3_262_1","doi-asserted-by":"publisher","DOI":"10.3923\/ajsr.2011.1.15"},{"issue":"5","key":"e_1_3_3_263_1","first-page":"661","article-title":"Sphingosomes A novel approach to vesicular drug delivery","volume":"4","author":"Saraf S.","year":"2011","unstructured":"Saraf, S., et\u00a0al., 2011. Sphingosomes A novel approach to vesicular drug delivery. Research journal of pharmacy and technology, 4 (5), 661\u2013666.","journal-title":"Research journal of pharmacy and technology"},{"key":"e_1_3_3_264_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-0414"},{"key":"e_1_3_3_265_1","doi-asserted-by":"publisher","DOI":"10.1080\/03639045.2017.1342654"},{"key":"e_1_3_3_266_1","doi-asserted-by":"publisher","DOI":"10.1211\/0022357021771896"},{"key":"e_1_3_3_267_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425240902967607"},{"key":"e_1_3_3_268_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-4165(85)90174-6"},{"key":"e_1_3_3_269_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1525-0016(16)35855-5"},{"key":"e_1_3_3_270_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2015.00286"},{"key":"e_1_3_3_271_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20199"},{"key":"e_1_3_3_272_1","doi-asserted-by":"publisher","DOI":"10.4103\/0975-8453.59509"},{"key":"e_1_3_3_273_1","doi-asserted-by":"publisher","DOI":"10.22270\/jddt.v8i6-s.2163"},{"key":"e_1_3_3_274_1","doi-asserted-by":"publisher","DOI":"10.22159\/ijap.2017v9i6.22556"},{"key":"e_1_3_3_275_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.09.052"},{"key":"e_1_3_3_276_1","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v24.i4.20"},{"key":"e_1_3_3_277_1","doi-asserted-by":"publisher","DOI":"10.1039\/C1NR11273B"},{"key":"e_1_3_3_278_1","first-page":"184","article-title":"Novasome-A breakthrough in pharmaceutical technology a review article","volume":"5","author":"Singh A.","year":"2011","unstructured":"Singh, A., Malviya, R., and Sharma, P., 2011. Novasome-A breakthrough in pharmaceutical technology a review article. Advances in biological research, 5, 184\u2013189.","journal-title":"Advances in biological research"},{"key":"e_1_3_3_279_1","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i5.10"},{"key":"e_1_3_3_280_1","doi-asserted-by":"publisher","DOI":"10.5958\/0974-360X.2018.00925.3"},{"issue":"3","key":"e_1_3_3_281_1","first-page":"114","article-title":"A review of absorption characteristics of microemulsion cyclosporine products over the last 2 years in Indian subjects","volume":"97","author":"Singh S.","year":"1999","unstructured":"Singh, S. and Sharma, D.R., 1999. A review of absorption characteristics of microemulsion cyclosporine products over the last 2 years in Indian subjects. Journal of Indian Medical Association, 97 (3), 114\u2013117. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10652912","journal-title":"Journal of Indian Medical Association"},{"key":"e_1_3_3_282_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-816506-5.00005-X"},{"key":"e_1_3_3_283_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu11112758"},{"key":"e_1_3_3_284_1","doi-asserted-by":"publisher","DOI":"10.3109\/02652049509010293"},{"key":"e_1_3_3_285_1","doi-asserted-by":"crossref","unstructured":"Sprott G.D. Patel G.B. and Krishnan L. 2003. Archaeobacterial ether lipid liposomes as vaccine adjuvants 155\u201372. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0076687903730110","DOI":"10.1016\/S0076-6879(03)73011-0"},{"key":"e_1_3_3_286_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1011-1344(01)00246-9"},{"key":"e_1_3_3_287_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-016-0538-7"},{"key":"e_1_3_3_288_1","doi-asserted-by":"publisher","DOI":"10.22270\/jddt.v9i1-s.2234"},{"key":"e_1_3_3_289_1","doi-asserted-by":"publisher","DOI":"10.4103\/0250-474X.25707"},{"key":"e_1_3_3_290_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics5030498"},{"key":"e_1_3_3_291_1","doi-asserted-by":"publisher","DOI":"10.3109\/10611869609015970"},{"key":"e_1_3_3_292_1","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7834159"},{"key":"e_1_3_3_293_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2004.04.002"},{"issue":"5","key":"e_1_3_3_294_1","first-page":"40","article-title":"Saquinavir as Fortovase: why does it matter?","volume":"10","author":"Trapnell C.B.","year":"1998","unstructured":"Trapnell, C.B., 1998. Saquinavir as Fortovase: why does it matter? AIDS clinical care, 10 (5), 40. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11365428","journal-title":"AIDS clinical care"},{"key":"e_1_3_3_295_1","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9797(90)90167-M"},{"key":"e_1_3_3_296_1","doi-asserted-by":"publisher","DOI":"10.1081\/DDC-200047850"},{"key":"e_1_3_3_297_1","unstructured":"US Compendial Nomenclature 2022. Available from: https:\/\/www.usp.org\/health-quality-safety\/compendial-nomenclature"},{"key":"e_1_3_3_298_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(03)00180-7"},{"key":"e_1_3_3_299_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejlt.201400219"},{"key":"e_1_3_3_300_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2017.07.008"},{"key":"e_1_3_3_301_1","doi-asserted-by":"publisher","DOI":"10.3390\/scipharm88020017"},{"key":"e_1_3_3_302_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2005.11.014"},{"key":"e_1_3_3_303_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2004.02.028"},{"key":"e_1_3_3_304_1","doi-asserted-by":"publisher","DOI":"10.1211\/jpp.58.3.0005"},{"key":"e_1_3_3_305_1","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/591325"},{"key":"e_1_3_3_306_1","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2019.00872\/full"},{"key":"e_1_3_3_307_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2015.1021681"},{"key":"e_1_3_3_308_1","doi-asserted-by":"crossref","unstructured":"Wang L. Hu C. and Shao L. 2017. The antimicrobial activity of nanoparticles: present situation and prospects for the future. International journal of nanomedicine 12 1227\u20131249. Available from: https:\/\/www.dovepress.com\/the-antimicrobial-activity-of-nanoparticles-present-situation-and-pros-peer-reviewed-article-IJN","DOI":"10.2147\/IJN.S121956"},{"key":"e_1_3_3_309_1","doi-asserted-by":"publisher","DOI":"10.1038\/46587"},{"key":"e_1_3_3_310_1","unstructured":"WHO 1973. WHO food additives series No. 5. Available from: http:\/\/www.inchem.org\/documents\/jecfa\/jecmono\/v05je42.htm"},{"key":"e_1_3_3_311_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.60.070191.000445"},{"key":"e_1_3_3_312_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.7b00170"},{"key":"e_1_3_3_313_1","doi-asserted-by":"crossref","unstructured":"Woodle M.C. and Papahadjopoulos D. 1989. [9] Liposome preparation and size characterization 193\u2013217. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0076687989710120","DOI":"10.1016\/S0076-6879(89)71012-0"},{"key":"e_1_3_3_314_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2011.07.012"},{"key":"e_1_3_3_315_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2011.11.036"},{"key":"e_1_3_3_316_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics6030378"},{"key":"e_1_3_3_317_1","doi-asserted-by":"publisher","DOI":"10.1080\/00268948408071454"},{"key":"e_1_3_3_318_1","doi-asserted-by":"publisher","DOI":"10.5650\/jos.ess18181"},{"key":"e_1_3_3_319_1","doi-asserted-by":"publisher","DOI":"10.1039\/C7AY00592J"},{"key":"e_1_3_3_320_1","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2020.00286\/full"},{"key":"e_1_3_3_321_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12050407"},{"key":"e_1_3_3_322_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10030074"},{"key":"e_1_3_3_323_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-1252-0_11"},{"key":"e_1_3_3_324_1","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e3182937b74"},{"key":"e_1_3_3_325_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2016.10.021"}],"container-title":["Journal of Liposome Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/08982104.2022.2069809","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:32:18Z","timestamp":1761589938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/08982104.2022.2069809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,11]]},"references-count":324,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,2]]}},"alternative-id":["10.1080\/08982104.2022.2069809"],"URL":"https:\/\/doi.org\/10.1080\/08982104.2022.2069809","relation":{},"ISSN":["0898-2104","1532-2394"],"issn-type":[{"value":"0898-2104","type":"print"},{"value":"1532-2394","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilpr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilpr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-12-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}